The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004
Open accessAbstract
The extent to which clonal spread contributes to emerging antimicrobial resistance in Escherichia coli is incompletely defined. To address this question within a recent, nationally representative strain collection, three established drug-resistant E. coli clonal groups (i.e., clonal group A, E. coli O15:K52:H1, and sequence type 131 [ST131]) were sought among 199 E. coli urine isolates recovered from across Canada from 2002 to 2004, with stratification by resistance to trimethoprim-sulfamethoxazole (TS) and fluoroquinolones (FQs). The isolates' clonal backgrounds, virulence genotypes, and macrorestriction profiles were assessed. The three clonal groups were found to account for 37.2% of isolates overall, but accounted for 0% of TS-susceptible (TS-S) and FQ-susceptible (FQ-S) isolates, 20% of TS-resistant (TS-R) and FQ-S isolates, 60% of TS-S and FQ-R isolates, and 68% of TS-R and FQ-R isolates ( P < 0.001). E. coli ST131, the most prevalent clonal group, accounted for 23.1% of isolates overall and for 44% of the FQ-R isolates. Nearly all ST131 isolates were FQ-R (96%) but, notably, cephalosporin susceptible (98%). Although the distinctive virulence profiles of the FQ-R clonal group isolates were less extensive than those of the susceptible isolates, they were significantly more extensive than those of the other FQ-R isolates. These findings indicate that among the E. coli urine isolates studied, resistance to TS and FQs has a prominent clonal component, with the O15:K52:H1 clonal group and especially E. coli ST131 being the major contributors. These clonal groups appear to be more virulent than comparably resistant isolates, possibly contributing to their success as emerging multi-drug-resistant pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Rapid and Simple Determination of the Escherichia coli Phylogenetic Group
Clermont, O., Bonacorsi, S., & Bingen, E. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.10.4555-4558.2000 · Cited by 2,645
Johnson, J. R., & Stell, A. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315217 · Cited by 1,269
Self-citationIntercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 821
Self-citationEmergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Gupta, K., Hooton, T. M., & Stamm, W. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-1-200107030-00012 · Cited by 677
Manges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Self-citationEmergence and Dissemination of Quinolone-Resistant Escherichia coli in the Community
Garau, J., Xercavins, M., Rodríguez-Carballeira, M., Gómez-Vera, J. R., Coll, I., Vidal, D., Llovet, T., & Ruíz-Bremón, A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2736 · Cited by 337
ZHANEL, G., HISANAGA, T., LAING, N., DECORBY, M., NICHOL, K., WESHNOWESKI, B., JOHNSON, J., NOREDDIN, A., LOW, D., & KARLOWSKY, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.02.009 · Cited by 302
Self-citationClermont, O., Lavollay, M., Vimont, S., Deschamps, C., Forestier, C., Branger, C., Denamur, E., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn084 · Cited by 274
Zhanel, G. G., Hisanaga, T. L., Laing, N. M., DeCorby, M. R., Nichol, K. A., Palatnick, L. P., Johnson, J., Noreddin, A., Harding, G. K. M., Nicolle, L. E., et al. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.08.003 · Cited by 235
Self-citationMolecular Epidemiology and Phylogenetic Distribution of the Escherichia coli pks Genomic Island
Johnson, J. R., Johnston, B., Kuskowski, M. A., Nougayrede, J.-P., & Oswald, E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00949-08 · Cited by 194
Self-citationCagnacci, S., Gualco, L., Debbia, E., Schito, G. C., & Marchese, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
Leflon‐Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelfi, M.-C., Duportail, F., Heym, B., Bingen, É., & Nicolas-Chanoine, M.-H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3736-3742.2004 · Cited by 149
Pitout, J. D. D., Church, D. L., Gregson, D. B., Chow, B. L., McCracken, M., Mulvey, M. R., & Laupland, K. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01377-06 · Cited by 144
Leflon‐Guibout, V., Blanco, J., Amaqdouf, K., Mora, A., Guize, L., & Nicolas-Chanoine, M.-H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00734-08 · Cited by 144
Clermont, O., Johnson, J. R., Menard, M. L., & Denamur, É. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.08.007 · Cited by 130
Self-citationEPIDEMIC MULTIRESISTANT ESCHERICHIA COLI INFECTION IN WEST LAMBETH HEALTH DISTRICT
Phillips, I., King, A., Rowe, B., Eykyn, S. J., Gransden, W. R., Frost, J. A., & Gross, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91853-3 · Cited by 119
Endemic and Epidemic Lineages ofEscherichia colithat Cause Urinary Tract Infections
Manges, A. R., Tabor, H., Tellis, P. A., Vincent, C., & Tellier, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1410.080102 · Cited by 115
A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis
Johnson, J. R., Manges, A. R., O’Bryan, T. T., & Riley, L. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09264-4 · Cited by 114
Self-citationDistribution and Characteristics ofEscherichia coliClonal Group A1
Johnson, J. R., Murray, A. C., Kuskowski, M. A., Schubert, S., Prère, M. F., Picard, B., Colodner, R., Raz, R., & and the Trans-Global Initiative for Antimicrobial Resistance Analysis (TIARA) Investigators (2005) · Emerging infectious diseases · doi:10.3201/eid1101.040418 · Cited by 81
Self-citationJohnson, J. R., Stell, A. L., Scheutz, F., O’Bryan, T. T., Russo, T. A., Carlino, U. B., Fasching, C. E., Kavle, J. A., van Dijk, L., & Gaastra, W. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1587-1599.2000 · Cited by 79
Self-citationBurman, W. J., Breese, P. E., Murray, B. E., Singh, K. V., Batal, H. A., MacKenzie, T. D., Ogle, J. W., Wilson, M. L., Reves, R. R., & Mehler, P. S. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00372-3 · Cited by 75
Escherichia coli Serotype O15:K52:H1 as a Uropathogenic Clone
Prats, G., Navarro, F., Mirelis, B., Dalmau, D., Margall, N., Coll, P., Stell, A. L., & Johnson, J. R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.201-209.2000 · Cited by 66
Self-citationRapid and Specific Detection of Escherichia coli Clonal Group A by Gene-Specific PCR
Johnson, J. R., Owens, K., Manges, A. R., & Riley, L. W. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2618-2622.2004 · Cited by 64
Self-citationJohnson, J. R., Stell, A. L., O’Bryan, T. T., Kuskowski, M. A., Nowicki, B. J., Johnson, C. E., Maslow, J. N., Kaul, A., Kavle, J. A., & Prats, G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.1913-1923.2002 · Cited by 56
Self-citationThe rise and fall of Escherichia coli O 15 in a London Teaching Hospital
NEILL, P. M. O., Talboys, C. A., ROBERTS, A. P., & Azadian, B. S. (1990) · Journal of Medical Microbiology · doi:10.1099/00222615-33-1-23 · Cited by 25
Rapid and Specific Detection of the O15:K52:H1 Clonal Group of Escherichia coli by Gene-Specific PCR
Johnson, J. R., Owens, K., Sabate, M., & Prats, G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3841-3843.2004 · Cited by 23
Self-citationEscherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen
Dalmau, D., Navarro, F., Mirelis, B., Blanco, J., Garau, J., & Prats, G. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90073-0 · Cited by 19
Cited by
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Tacconelli, E., Cataldo, M. A., Dancer, S. J., De Angelis, G., Falcone, M., Frank, U., Kahlmeter, G., Pan, A., Petrosillo, N., Rodríguez-Baño, J., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12427 · Cited by 864
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Self-citation
Metadata
- Authors
- Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., & Zhanel, G. G.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-07
- Volume
- 53
- Issue
- 7
- Pages
- 2733-2739
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2126990727
- Cited by
- 265
- References
- 30
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.